Calcium-sensing receptor autoantibodies and idiopathic hypoparathyroidism

Journal of Clinical Endocrinology and Metabolism

Volumn 98, Issue 9, 2013, Pages 3884-3891

  Tomar, Neeraj ^a   Gupta, Nandita ^a   Goswami, Ravinder ^a  

^a ALL INDIA INSTITUTE OF MEDICAL SCIENCES   (India)

Author keywords

[No Author keywords available]

Indexed keywords

AUTOANTIBODY; CALCIUM SENSING RECEPTOR; CALCIUM SENSING RECEPTOR ANTIBODY; MITOGEN ACTIVATED PROTEIN KINASE 1; MITOGEN ACTIVATED PROTEIN KINASE 3; PARATHYROID HORMONE; UNCLASSIFIED DRUG;

ADULT; AGED; ARTICLE; AUTOIMMUNITY; CASE CONTROL STUDY; CASR GENE; CELL STRAIN HEK293; COMORBIDITY; CONTROLLED STUDY; DIAGNOSTIC TEST ACCURACY STUDY; DISEASE DURATION; EMBRYO; ENZYME LINKED IMMUNOSORBENT ASSAY; ENZYME PHOSPHORYLATION; ESCHERICHIA COLI; FEMALE; GENE MUTATION; GENE SEQUENCE; HASHIMOTO DISEASE; HUMAN; HUMAN CELL; IDIOPATHIC HYPOPARATHYROIDISM; IMMUNOFLUORESCENCE; IMMUNOPRECIPITATION; INSULIN DEPENDENT DIABETES MELLITUS; MAJOR CLINICAL STUDY; MALE; MOLECULAR WEIGHT; NONHUMAN; PREDICTIVE VALUE; PREVALENCE; PRIORITY JOURNAL; PTH GENE; SENSITIVITY AND SPECIFICITY; WESTERN BLOTTING;

ADOLESCENT; ADULT; AGED; AUTOANTIBODIES; CASE-CONTROL STUDIES; DIABETES MELLITUS, TYPE 1; FEMALE; HASHIMOTO DISEASE; HEK293 CELLS; HUMANS; HYPOPARATHYROIDISM; MALE; MAP KINASE SIGNALING SYSTEM; MIDDLE AGED; PARATHYROID HORMONE; PHOSPHORYLATION; RECEPTORS, CALCIUM-SENSING;

EID: 84883676359     PISSN: 0021972X     EISSN: 19457197     Source Type: Journal    
DOI: 10.1210/jc.2013-2158     Document Type: Article

References (33)

1. Blizzard RM, Chee D, Davis W. The incidence of parathyroid and other antibodies in the sera of patients with idiopathic hypoparathyroidism. Clin Exp Immunol. 1966;1:119-128.
2. Rose NR. Is idiopathic hyperparathyroidism an autoimmune disease? J Clin Invest. 1996;97:899-900.
3. Downs RW. The hypoparathyroid states. In: Bilezikian JP, Marcus R, LevineMA,eds. The Parathyroid: Basics and Clinical Aspect. 2nd ed. Boston: Academic Press; 2001:755-762.
4. Shoback D. Clinical practice. Hypoparathyroidism. N Engl J Med. 2008;359:391-403.
5. Goswami R, Mohapatra T, Gupta N, et al. Parathyroid hormone gene polymorphism and sporadic idiopathic hypoparathyroidism. J Clin Endocrinol Metab. 2004;89:4840-4845.
6. Sarin R, Tomar N, Debarti R, Gupta N, Sharma YD, Goswami R. Absence of pathogenic calcium sensing receptor gene mutations in sporadic idiopathic hypoparathyroidism. Clin Endocrinol (Oxf). 2006;65:359-363.
7. Tomar N, Bora H, Singh R, et al. Presence and significance of a R110W mutation in the DNA-binding domain of GCM2 gene in patients with isolated hypoparathyroidism and their family members. Eur J Endocrinol. 2010;162:407-421.
8. Li Y, Song YH, Rais N, et al. Autoantibodies to the extracellular domain of the calcium sensing receptor in patients with acquired hypoparathyroidism. J Clin Invest. 1996;97:910-914.
9. Mayer A, Ploix C, Orgiazzi J, et al. Calcium-sensing receptor autoantibodies are relevant markers of acquired hypoparathyroidism. J Clin Endocrinol Metab. 2004;89:4484-4488.
10. Goswami R, Brown EM, Kochupillai N, et al. Prevalence of calcium sensing receptor autoantibodies in patients with sporadic idiopathic hypoparathyroidism. Eur J Endocrinol. 2004;150:9-18.
11. Gavalas NG, Kemp EH, Krohn KJ, Brown EM, Watson PF, Wheetman AP. The calcium-sensing receptor is a target of autoantibodies in patients with autoimmune polyendocrine syndrome type 1. J Clin Endocrinol Metab. 2007;92:2107-2114.
12. Soderbergh A, Myhre AG, Ekwall O, et al. Prevalence and clinical associations of 10 defined autoantibodies in autoimmune polyendocrine syndrome type I. J Clin Endocrinol Metab. 2004;89:557-562.
13. Alimohammadi M, Björklund P, Hallgren A, et al. Autoimmune polyendocrine syndrome type 1 and NALP5, a parathyroid autoantigen. N Engl J Med. 2008;358:1018-1028.
14. Tomar N, Kaushal E, Das M, Gupta N, Betterle C, Goswami R. Prevalence and significance of NALP5 autoantibodies in patients with idiopathichypoparathyroidism. J Clin Endocrinol Metab. 2012;97:1219-1226.
15. Goswami R, Marwaha RK, Gupta N, et al. Prevalence of vitamin D deficiency and its relationship with thyroid autoimmunity in Asian Indians: a community-based survey. Br J Nutr. 2009;102:382-386.
16. Goswami, R, Marwaha, RK, Goswami, D, et al. Prevalence of thyroid autoimmunity in sporadic idiopathic hypoparathyroidism in comparison to type 1 diabetes and premature ovarian failure. J Clin Endocrinol Metab. 2006;91:4256-4259.
17. Bilous RW, Murty G, Parkinson DB, et al. Brief report: autosomal dominant familial hypoparathyroidism, sensorineural deafness, and renal dysplasia. N Engl J Med. 1992;327:1069-1074.
18. Sambrook J, RussellDW.Plasmids and their usefulness in molecular cloning. In: Sambrook J, Russell DW, eds. Molecular Cloning-A Laboratory Manual. 3rd ed. Cold Spring Harbor, NY: Cold Spring Harbor Laboratory; 2001;1.116-1.118.
19. Vezzoli G, Terranegra A, Arcidiacono T, et al. R990G polymorphism of calcium-sensing receptor does produce a gain-of-function and predispose to primary hypercalciuria. Kidney Int. 2007;71: 1155-1162.
20. Kifor O, McElduff A, LeBoff MS, et al. Activating antibodies to the calcium-sensing receptor in two patients with autoimmune hypoparathyroidism. J Clin Endocrinol Metab. 2004;89:548-556.
21. Harlow E, Lane D. Antibodies: a laboratory manual. Cold Spring Harbor, NY: Cold Spring Harbor Laboratory Press; 1988.
22. Bai M, Janicic N, Trivedi S, et al. Markedly reduced activity of mutant calcium-sensing receptor with an inserted Alu element from a kindred with familial hypocalciuric hypercalcemia and neonatal severe hyperparathyroidism. J Clin Invest. 1997;99:1917-1925.
23. MacLeod RJ, Chattopadhyay N, Brown EM. PTHrP stimulated by the calcium-sensing receptor requires MAP kinase activation. Am J Physiol Endocrinol Metab. 2003;284:435-442.
24. Kemp EH, Gavalas NG, Akhtar S, et al. Mapping of human autoantibody binding sites on the calcium-sensing receptor. J Bone Miner Res. 2010;25:132-140.
25. Betterle C, Caretto A, Zeviani M, Pedini B, Salviati C. Demonstration and characterization of anti-human mitochondria autoantibodies in idiopathic hypoparathyroidism and in other conditions. Clin Exp Immunol. 1985;62:353-360.
26. KempEH,GavalasNG,KrohnKJ,BrownEM,WatsonPF,WeetmanAP. Activating autoantibodies against the calcium-sensing receptor detected in two patients with autoimmune polyendocrine syndrome type 1. J Clin Endocrinol Metab. 2009;94:4749-4756.
27. Gylling M, Kääriäinen E, Väisänen R, et al. The hypoparathyroidism of autoimmune polyendocrinopathy-candidiasis-ectodermal dystrophy protective effect of male sex. J Clin Endocrinol Metab. 2003;88:4602-4608.
28. Tuomi T, Rowley MJ, Knowles WJ, et al. Autoantigenic properties of native and denatured glutamic acid decarboxylase: evidence for a conformational epitope. Clin Immunol Immunopathol. 1994;71: 53-59.
29. Gangwar M, Khan ZU, Gaur SN, Randhawa HS. Occurrence and significance of precipitating antibodies against thermophilic actinomycetes in the sera of dairy herd workers, Nangali, Delhi. Antonie Van Leeuwenhoek. 1991;59:167-175.
30. Drasar BS, Goddard P, Heaton S, Peach S, West B. Clostridia isolated from faeces. J Med Microbiol. 1976;9:63-71.
31. Brandi ML, Aurbach GD, Fattorossi A, Quarto R, Marx SJ, Fitzpatrick LA. Antibodies cytotoxic to bovine parathyroid cells in autoimmune hypoparathyroidism. PNAS. 1986;83:8366-8369.
32. Rebuffat SA, Nguyen B, Robert B, Castex F, Peraldi-Roux S. Antithyroperoxidase antibody-dependent cytotoxicity in autoimmune thyroid disease. J Clin Endocrinol Metab. 2008;93:929-934.
33. Goswami R, Singh A, Gupta N; Indian Genome Variation Consortium, Rani R. Presence of strong association of the major histocompatibility complex (MHC) class I allele HLA-A26:01 with idiopathic hypoparathyroidism. J Clin Endocrinol Metab. 2012;97: E1820-E1824.